call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Oligonucleotide Synthesis Market
Inquire Before Buying Request for Sample

Oligonucleotide Synthesis Market

Home Healthcare And Pharmaceutical Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Services (Oligonucleotide Synthesis Products (Oligonucleotide Synthesis Equipment - Synthesizers, Oligonucleotide Synthesis Reagents & Consumables), Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, Small-Scale Oligonucleotide Synthesis); By Application (Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy (CpG Oligonucleotide-based Therapies), Nucleic Acid Aptamers), Diagnostics); By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: January 2023
  • Report ID: BWC22580
  • Available Format: PDF
  • Page: 240

Report Overview

Rising autoimmune disease prevalence, expanding use of oligonucleotide synthesis, rising biosimilars' cost-effectiveness, rising government investments in healthcare infrastructure, and rising research and development capabilities could boost the growth of Global Oligonucleotide Synthesis Market during the forecast period between 2023 and 2029.

Global Oligonucleotide Synthesis Market - Industry Trends & Forecast Report, 2029

Global oligonucleotide synthesis market size is estimated at USD 5.99 billion in 2022. During the forecast period between 2023 and 2029, the size of global oligonucleotide synthesis market is projected to grow at a CAGR of 11.6% reaching a value of USD 12.94 billion by 2029. In research, genetic testing, drug development, and forensic applications, the demand for custom-made nucleotides for the desired sequence have increased due to the falling cost of sequencing. As a result, oligonucleotide synthesis is more in demand across a variety of life science applications. Numerous ongoing genetic research studies heavily rely on oligonucleotide synthesis. The demand for a custom synthesis of various classes of oligos, such as decoys, aptamers, immunostimulatory, antisense, siRNA, and miRNA, is expected to increase as genetic research funding increases. Several significant and up-and-coming producers of oligonucleotides are working with pharmaceutical manufacturers to expand their businesses. For instance, CordenPharma International and GE Healthcare Dharmacon Inc., signed a strategic collaboration agreement in June 2017 to develop an end-to-end oligonucleotide-based drug discovery solution.

Global Oligonucleotide Synthesis Market

Global Oligonucleotide Synthesis Market - Overview

Short nucleic acid fragments are joined together chemically in a process known as oligonucleotide synthesis to create desired sequenced products. Researchers can alter it by the application and their needs. It is utilized in recombinant DNA technologies to create monoclonal antibodies as primers and probes. Additionally, it is used for gene expression, cloning, molecular diagnostics, and screening for genetic diseases in biological, medical, forensic, and clinical applications. Additionally, it is becoming more popular in the therapeutic use of several medications because of the development of automated reactor platforms, which make oligonucleotides available at affordable prices.

Global Oligonucleotide Synthesis Market

Growth Drivers

Falling cost of sequencing driving oligonucleotide synthesis market

Over the last few years, advances in genomics research have resulted in a significant reduction in the cost of genome sequencing. NGS technology has significantly reduced the cost and increased the speed of DNA sequencing. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has dropped significantly from about USD 5 million in 2008 to about USD 1,000 in 2017. Sequencing is increasingly being used in genomics research not only to assemble genomes and investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology, and infectious diseases. As a result, the rapidly falling cost of sequencing is expected to boost research activities, fueling the demand for oligonucleotide synthesis products and technologies during the forecast period.

Significant opportunities in emerging Asian markets

For different market participants in the oligonucleotide synthesis industry, developed nations, such as the United States, have been the most important markets. But low-penetration emerging markets are expected to witness significant growth over the next few years due to an increase in oligonucleotide demand; R&D spending; proteomics, genomics, and metabolomics research; and in healthcare costs; and ongoing improvements in the healthcare system. For the past few years, market participants in the oligonucleotide synthesis industry have identified the Asia-Pacific region's emerging economies—including China, India, and Association of Southeast Asian Nations (ASEAN) members—as being particularly lucrative. The aging population, expanding healthcare system, and growing middle class in China are all contributing to the country's significant growth in the demand for genetic sequencing. For instance, in 2016, the Chinese Academy of Sciences introduced a USD 9.2-billion, 14-year project - The Precision Medicine Initiative - to sequence more than 100 million human genomes by 2030.

Restraints

In-house oligonucleotide development could affect growth of service providers

In-house oligonucleotide development has an impact on service providers' sales, according to a recent trend. Academic and research institutions are primarily responsible for this internal development. To maintain privacy and simplify manufacturing, biopharmaceutical companies have begun developing oligonucleotides themselves or have given contracts to other organizations. However, limited requirements and budgetary restrictions are impossible to monitor, which tends to reduce the market's potential. Due to a lack of resources, the global market may also experience growth restrictions. Research funding for academic laboratories is anticipated to be limited, which could restrain the growth of global oligonucleotide synthesis market. Additionally, some regions only have a small number of market participants, and there is a labor shortage. These elements might prevent the expansion of research activities in oligonucleotide synthesis.

Impact of COVID-19 on Global Oligonucleotide Synthesis Market

The newest novel coronavirus, COVID-19, is the infectious disease that it causes. Before the outbreak's start in Wuhan (China) in December 2019, COVID-19 was largely unknown. It became a global pandemic. The COVID-19 outbreak was formally classified as a pandemic by the World Health Organization (WHO). A variety of well-known pharmaceutical and biopharmaceutical firms stepped forward to support global research initiatives by offering oligo products for creating test kits, medications, and vaccines that target the infection caused by the novel Coronavirus. They joined forces with players in the oligonucleotide synthesis market. In April 2021, for example, Microsynth AG (Switzerland) provided key reagents, such as primer-probe sets to PCR testing labs to assist molecular diagnostic companies in developing and validating accurate, cutting-edge detection methods, as well as to provide comprehensive genomics expertise to research labs studying coronaviruses.

Global Oligonucleotide Synthesis Market

Segmental Coverage

Global Oligonucleotide Synthesis Market - By Product and Services

Global oligonucleotide synthesis market is divided into Oligonucleotide Synthesis Products - Oligonucleotide Synthesis Equipment (Synthesizers) and Oligonucleotide Synthesis Reagents & Consumables, Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, and Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, and Small-Scale Oligonucleotide Synthesis). The oligonucleotide synthesis products segment is expected to account for a significant market share in the oligonucleotide synthesis market. The widespread use of synthesizers and consumables, such as PCR primers in PCR studies, has resulted in a higher proportion of synthesis products. The widespread use of PCR technologies in research and diagnostic fields, owing to their ease of use, high sensitivity, and low cost, is fueling the segment growth.

Oligonucleotide Synthesis Market Share

Global Oligonucleotide Synthesis Market - By Application

On basis of the application, global oligonucleotide synthesis market is divided into Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, and Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy [CpG Oligonucleotide-based Therapies], and Nucleic Acid Aptamers), and Diagnostics. The research segment is expected to hold the highest market share in the global oligonucleotide synthesis market by application. However, due to the growing applications of molecular diagnostics (MDx) and genetic testing, the use of oligonucleotides for diagnostic applications is projected to grow at the fastest CAGR during the forecast period. For target screening and identification in drug development, PCR primers are frequently used. PCR primers currently hold the largest revenue share in the oligonucleotide synthesis market due to the presence of a strong pipeline of oligonucleotide-based therapeutics, including antisense therapeutics, DNA vaccines, and anti-viral agents, in various stages of clinical development.

Global Oligonucleotide Synthesis Market - By End User

On basis of end user, global oligonucleotide synthesis market is divided into Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, and other segments. Pharmaceutical and biotechnology companies are concentrating on finding alternative methods of treating diseases. As oligonucleotides provide an efficient mode of action for the treatment of a variety of indications at comparatively low development costs, these companies are heavily utilizing them. Additionally, oligonucleotides are crucial in resolving issues with the most effective drug administration route. The production of oligonucleotide therapeutics is then expected to rise, increasing the market share of pharmaceutical and biotechnology firms across countries. Infrastructure for education and research is being developed in emerging economies with funding from both public and private sources. This aspect is expected to encourage the use of oligonucleotides in academic research facilities.

Global Oligonucleotide Synthesis Market - By Region

Geographically, global oligonucleotide synthesis market covers five major markets: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to its rapid advancement in genomic studies, Asia Pacific is expected to record grow at the fastest rate with the rising adoption of sequencing, array technology, and PCR products. The most lucrative markets in the area for genomics investments are China and Japan. Additionally, it is expected that an increase in product launches and approvals will positively influence the market expansion. For instance, in December 2020, China approved the clinical use of Illumina's NextSeq 550Dx for use in genetic testing and diagnosis.

Competitive Landscape

Global oligonucleotide synthesis market is highly competitive. Prominent players in the market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, and Maravai LifeSciences. The key strategies used by these market leaders are new product launches, mergers & acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Recent Developments

  • In May 2022, Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science communities introduced new extra-large Drying Traps (up to 4 liters of acetonitrile solution) for research application. These new DNA moisture traps can be used for maintaining moisture-free environments in oligonucleotide synthesis.

  • In April 2022, Ansa Biotech raised USD 68 million to launch a customizable DNA synthesis service, stemming from the development of a novel synthesis method. The funds will support the company’s DNA synthesis research and development efforts.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Product & Services, Application, End User, Region

Key Players

Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, Maravai LifeSciences

 

By Product & Services

  • Oligonucleotide Synthesis Products

  1. Oligonucleotide Synthesis Equipment (Synthesizers)

  2. Oligonucleotide Synthesis Reagents & Consumables

  • Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)

  1. Primers

  2. Probes

  3. Linkers & Adaptors

  • Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)

  1. Large-Scale Oligonucleotide Synthesis

  2. Intermediate-Scale Oligonucleotide Synthesis

  3. Small-Scale Oligonucleotide Synthesis

By Application

  • Research

  1. PCR

  2. qPCR/RTqPCR

  3. Sequencing

  4. Gene Synthesis

  5. Other Research Applications

  • Therapeutics

  1. RNAi Oligonucleotide-based Therapies

  2. DNA/Antisense oligonucleotide-based Therapies

  3. Immunotherapy (CpG Oligonucleotide-based Therapies)

  4. Nucleic Acid Aptamers

  • Diagnostics

By End User

  • Pharmaceutical and Biotechnology Companies

  • Academic & Research Institutes

  • Diagnostic Laboratories

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Oligonucleotide Synthesis Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Rising prevalence of autoimmune diseases
        2. Increasing adoption of Oligonucleotide Synthesis
        3. Growing number of cost-effective biosimilars
      2. Restraints
        1. Complexities in manufacturing
      3. Opportunities
        1. Rising research and development proficiencies
        2. Growing government investments on healthcare infrastructure
      4. Challenges
        1. Lack of standard protocols for developing software platforms
        2. Energy demand soars as EV sales soar
    3. Product Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Oligonucleotide Synthesis Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Services
        1. Oligonucleotide Synthesis Products
          1. Oligonucleotide Synthesis Equipment (Synthesizers)
          2. Oligonucleotide Synthesis Reagents & Consumables
        2. Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
          1. Primers
          2. Probes
          3. Linkers & Adaptors
        3. Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)
          1. Large-Scale Oligonucleotide Synthesis
          2. Intermediate-Scale Oligonucleotide Synthesis
          3. Small-Scale Oligonucleotide Synthesis
      2. By Application
        1. Research
          1. PCR
          2. qPCR/RTqPCR
          3. Sequencing
          4. Gene Synthesis
          5. Other Research Applications
        2. Therapeutics
          1. RNAi Oligonucleotide-based Therapies
          2. DNA/Antisense oligonucleotide-based Therapies
          3. Immunotherapy (CpG Oligonucleotide-based Therapies)
          4. Nucleic Acid Aptamers
        3. Diagnostics
      3. By End User
        1. Pharmaceutical and Biotechnology Companies
        2. Academic & Research Institutes
        3. Diagnostic Laboratories
        4. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America
        5. Middle East and Africa (MEA)
  5. North America Oligonucleotide Synthesis Market
      1. Market Size & Forecast, 2019–2029
      2. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Services
      2. By Application
      3. By End User
      4. By Country
        1. United States
          1. By Product & Services
          2. By Application
          3. By End User
        2. Canada
          1. By Product & Services
          2. By Application
          3. By End User
  6. Europe Oligonucleotide Synthesis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Services
      2. By Application
      3. By End User
      4. By Country
        1. Germany
          1. By Product & Services
          2. By Application
          3. By End User
        2. United Kingdom
          1. By Product & Services
          2. By Application
          3. By End User
        3. Italy
          1. By Product & Services
          2. By Application
          3. By End User
        4. France
          1. By Product & Services
          2. By Application
          3. By End User
        5. Spain
          1. By Product & Services
          2. By Application
          3. By End User
        6. The Netherlands
          1. By Product & Services
          2. By Application
          3. By End User
        7. Belgium
          1. By Product & Services
          2. By Application
          3. By End User
        8. NORDIC Countries
          1. By Product & Services
          2. By Application
          3. By End User
        9. Rest of Europe
          1. By Product & Services
          2. By Application
          3. By End User
  7. Asia-Pacific Oligonucleotide Synthesis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Services
      2. By Application
      3. By End User
      4. By Country
        1. China
          1. By Product & Services
          2. By Application
          3. By End User
        2. India
          1. By Product & Services
          2. By Application
          3. By End User
        3. Japan
          1. By Product & Services
          2. By Application
          3. By End User
        4. South Korea
          1. By Product & Services
          2. By Application
          3. By End User
        5. Australia & New Zealand
          1. By Product & Services
          2. By Application
          3. By End User
        6. Indonesia
          1. By Product & Services
          2. By Application
          3. By End User
        7. Malaysia
          1. By Product & Services
          2. By Application
          3. By End User
        8. Singapore
          1. By Product & Services
          2. By Application
          3. By End User
        9. Philippines
          1. By Product & Services
          2. By Application
          3. By End User
        10. Vietnam
          1. By Product & Services
          2. By Application
          3. By End User
        11. Rest of Asia Pacific
          1. By Product & Services
          2. By Application
          3. By End User
  8. Latin America Oligonucleotide Synthesis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product & Services
      2. By Application
      3. By End User
      4. By Country
        1. Brazil
          1. By Product & Services
          2. By Application
          3. By End User
        2. Mexico
          1. By Product & Services
          2. By Application
          3. By End User
        3. Argentina
          1. By Product & Services
          2. By Application
          3. By End User
        4. Peru
          1. By Product & Services
          2. By Application
          3. By End User
        5. Colombia
          1. By Product & Services
          2. By Application
          3. By End User
        6. Rest of Latin America
          1. By Product & Services
          2. By Application
          3. By End User
  9. Middle East & Africa Oligonucleotide Synthesis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product & Services
      2. By Application
      3. By End User
      4. By Country
        1. Saudi Arabia
          1. By Product & Services
          2. By Application
          3. By End User
        2. UAE
          1. By Product & Services
          2. By Application
          3. By End User
        3. Qatar
          1. By Product & Services
          2. By Application
          3. By End User
        4. Kuwait
          1. By Product & Services
          2. By Application
          3. By End User
        5. Iran
          1. By Product & Services
          2. By Application
          3. By End User
        6. South Africa
          1. By Product & Services
          2. By Application
          3. By End User
        7. Nigeria
          1. By Product & Services
          2. By Application
          3. By End User
        8. Kenya
          1. By Product & Services
          2. By Application
          3. By End User
        9. Egypt
          1. By Product & Services
          2. By Application
          3. By End User
        10. Morocco
          1. By Product & Services
          2. By Application
          3. By End User
        11. Algeria
          1. By Product & Services
          2. By Application
          3. By End User
        12. Rest of Middle East & Africa
          1. By Product & Services
          2. By Application
          3. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Essential Oils Company Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)
  11. Impact of Covid-19 on Global Oligonucleotide Synthesis Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Thermo Fisher Scientific
    2. Merck KGaA
    3. GE Healthcare
    4. Horizon Discovery Ltd.
    5. Agilent Technologies
    6. Kaneka Eurogentec S.A.
    7. Integrated DNA Technologies, Inc.
    8. LGC Biosearch Technologies
    9. Eurofins Genomics
    10. General Electric
    11. Genscript
    12. Danaher
    13. TriLink BioTechnologies
    14. Biolytic Lab Performance Inc.
    15. PolyGen GmbH
    16. Quintara Biosciences
    17. Twist Bioscience
    18. GENERI BIOTECH
    19. Ionis Pharmaceuticals
    20. Maravai LifeSciences
    21. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumptions & Limitations

 

*Financial information in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

 

List of Figures

Figure 1        Global Oligonucleotide Synthesis Market Segmentation

Figure 2        Global Oligonucleotide Synthesis Market Value Chain Analysis

Figure 3        Company Market Share Analysis, 2021

Figure 4        Global Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 5        Global Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 6        Global Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 7        Global Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 8        Global Oligonucleotide Synthesis Market Share, By Region, By Value, 2019–2029

Figure 9        North America Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 10       North America Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 11       North America Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 12       North America Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 13       North America Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 14       United States Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 15       United States Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 16       United States Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 17       United States Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 18       Canada Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 19       Canada Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 20       Canada Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 21       Canada Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 22       Europe Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 23       Europe Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 24       Europe Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 25       Europe Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 26       Europe Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 27       Germany Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 28       Germany Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 29       Germany Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 30       Germany Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 31       UK Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 32       UK Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 33       UK Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 34       UK Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 35       Italy Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 36       Italy Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 37       Italy Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 38       Italy Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 39       France Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 40       France Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 41       France Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 42       France Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 43       Spain Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 44       Spain Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 45       Spain Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 46       Spain Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 47       The Netherlands Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 48       The Netherlands Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 49       The Netherlands Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 50       The Netherlands Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 51       Belgium Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 52       Belgium Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 53       Belgium Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 54       Belgium Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 55       NORDIC Countries Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 56       NORDIC Countries Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 57       NORDIC Countries Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 58       NORDIC Countries Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 59       Rest of Europe Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 60       Rest of Europe Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 61       Rest of Europe Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 62       Rest of Europe Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 63       Asia-Pacific Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Figure 64       Asia-Pacific Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 65       Asia-Pacific Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 66       Asia-Pacific Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 67       Asia-Pacific Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 68       China Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 69       China Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 70       China Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 71       China Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 72       India Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 73       India Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 74       India Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 75       India Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 76       Japan Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 77       Japan Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 78       Japan Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 79       Japan Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 80       South Korea Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 81       South Korea Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 82       South Korea Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 83       South Korea Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 84       Australia & New Zealand Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 85       Australia & New Zealand Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 86       Australia & New Zealand Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 87       Australia & New Zealand Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 88       Indonesia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 89       Indonesia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 90       Indonesia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 91       Indonesia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 92       Malaysia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 93       Malaysia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 94       Malaysia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 95       Malaysia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 96       Singapore Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 97       Singapore Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 98       Singapore Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 99       Singapore Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 100     Philippines Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 101     Philippines Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 102     Philippines Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 103     Philippines Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 104     Vietnam Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 105     Vietnam Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 106     Vietnam Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 107     Vietnam Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 108     Rest of APAC Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 109     Rest of APAC Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 110     Rest of APAC Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 111     Rest of APAC Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 112     Latin America Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 113     Latin America Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 114     Latin America Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 115     Latin America Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 116     Latin America Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 117     Brazil Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 118     Brazil Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 119     Brazil Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 120     Brazil Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 121     Mexico Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 122     Mexico Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 123     Mexico Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 124     Mexico Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 125     Argentina Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 126     Argentina Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 127     Argentina Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 128     Argentina Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 129     Peru Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 130     Peru Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 131     Peru Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 132     Peru Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 133     Colombia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 134     Colombia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 135     Colombia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 136     Colombia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 137     Rest of LATAM Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 138     Rest of LATAM Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 139     Rest of LATAM Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 140     Rest of LATAM Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 141     Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 142     Middle East & Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 143     Middle East & Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 144     Middle East & Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 145     Middle East & Africa Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029

Figure 146     Saudi Arabia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 147     Saudi Arabia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 148     Saudi Arabia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 149     Saudi Arabia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 150     UAE Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 151     UAE Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 152     UAE Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 153     UAE Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 154     Qatar Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 155     Qatar Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 156     Qatar Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 157     Qatar Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 158     Kuwait Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 159     Kuwait Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 160     Kuwait Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 161     Kuwait Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 162     Iran Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 163     Iran Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 164     Iran Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 165     Iran Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 166     South Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 167     South Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 168     South Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 169     South Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 170     Nigeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 171     Nigeria Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 172     Nigeria Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 173     Nigeria Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 174     Kenya Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 175     Kenya Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 176     Kenya Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 177     Kenya Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 178     Egypt Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 179     Egypt Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 180     Egypt Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 181     Egypt Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 182     Morocco Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 183     Morocco Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 184     Morocco Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 185     Morocco Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 186     Algeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 187     Algeria Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 188     Algeria Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 189     Algeria Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

Figure 190     Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Figure 191     Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029

Figure 192     Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029

Figure 193     Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029

         

List of Tables          

Table 1         Global Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 2         Global Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 3         Global Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 4         Global Oligonucleotide Synthesis Market Size, By Region, By Value, 2019–2029

Table 5         North America Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 6         North America Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 7         North America Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 8         North America Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 9         North America Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 10        United States Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 11        United States Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 12        United States Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 13        United States Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 14        Canada Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 15        Canada Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 16        Canada Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 17        Canada Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 18        Europe Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 19        Europe Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 20        Europe Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 21        Europe Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 22        Europe Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 23        Germany Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 24        Germany Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 25        Germany Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 26        Germany Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 27        UK Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 28        UK Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 29        UK Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 30        UK Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 31        Italy Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 32        Italy Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 33        Italy Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 34        Italy Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 35        France Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 36        France Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 37        France Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 38        France Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 39        Spain Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 40        Spain Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 41        Spain Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 42        Spain Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 43        The Netherlands Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 44        The Netherlands Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 45        The Netherlands Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 46        The Netherlands Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 47        Belgium Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 48        Belgium Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 49        Belgium Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 50        Belgium Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 51        NORDIC Countries Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 52        NORDIC Countries Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 53        NORDIC Countries Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 54        NORDIC Countries Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 55        Rest of Europe Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 56        Rest of Europe Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 57        Rest of Europe Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 58        Rest of Europe Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 59        Asia-Pacific Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029

Table 60        Asia-Pacific Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 61        Asia-Pacific Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 62        Asia-Pacific Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 63        Asia-Pacific Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 64        China Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 65        China Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 66        China Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 67        China Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 68        India Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 69        India Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 70        India Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 71        India Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 72        Japan Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 73        Japan Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 74        Japan Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 75        Japan Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 76        South Korea Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 77        South Korea Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 78        South Korea Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 79        South Korea Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 80        Australia & New Zealand Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 81        Australia & New Zealand Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 82        Australia & New Zealand Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 83        Australia & New Zealand Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 84        Indonesia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 85        Indonesia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 86        Indonesia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 87        Indonesia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 88        Malaysia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 89        Malaysia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 90        Malaysia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 91        Malaysia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 92        Singapore Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 93        Singapore Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 94        Singapore Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 95        Singapore Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 96        Philippines Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 97        Philippines Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 98        Philippines Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 99        Philippines Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 100      Vietnam Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 101      Vietnam Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 102      Vietnam Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 103      Vietnam Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 104      Rest of APAC Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 105      Rest of APAC Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 106      Rest of APAC Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 107      Rest of APAC Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 108      Latin America Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 109      Latin America Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 110      Latin America Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 111      Latin America Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 112      Latin America Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 113      Brazil Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 114      Brazil Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 115      Brazil Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 116      Brazil Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 117      Mexico Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 118      Mexico Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 119      Mexico Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 120      Mexico Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 121      Argentina Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 122      Argentina Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 123      Argentina Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 124      Argentina Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 125      Peru Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 126      Peru Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 127      Peru Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 128      Peru Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 129      Colombia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 130      Colombia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 131      Colombia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 132      Colombia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 133      Rest of LATAM Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 134      Rest of LATAM Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 135      Rest of LATAM Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 136      Rest of LATAM Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 137      Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 138      Middle East & Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 139      Middle East & Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 140      Middle East & Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 141      Middle East & Africa Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029

Table 142      Saudi Arabia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 143      Saudi Arabia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 144      Saudi Arabia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 145      Saudi Arabia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 146      UAE Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 147      UAE Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 148      UAE Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 149      UAE Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 150      Qatar Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 151      Qatar Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 152      Qatar Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 153      Qatar Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 154      Kuwait Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 155      Kuwait Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 156      Kuwait Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 157      Kuwait Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 158      Iran Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 159      Iran Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 160      Iran Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 161      Iran Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 162      South Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 163      South Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 164      South Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 165      South Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 166      Nigeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 167      Nigeria Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 168      Nigeria Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 169      Nigeria Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 170      Kenya Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 171      Kenya Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 172      Kenya Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 173      Kenya Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 174      Egypt Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 175      Egypt Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 176      Egypt Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 177      Egypt Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 178      Morocco Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 179      Morocco Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 180      Morocco Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 181      Morocco Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 182      Algeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 183      Algeria Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 184      Algeria Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 185      Algeria Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 186      Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029

Table 187      Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029

Table 188      Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029

Table 189      Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029

Table 190      Thermo Fisher Scientific Company Overview

Table 191      Thermo Fisher Scientific Financial Overview

Table 192      Merck KGaA Company Overview

Table 193      Merck KGaA Financial Overview

Table 194      GE Healthcare Company Overview

Table 195      GE Healthcare Financial Overview

Table 196      Horizon Discovery Ltd. Company Overview

Table 197      Horizon Discovery Ltd. Financial Overview

Table 198      Agilent Technologies Company Overview

Table 199      Agilent Technologies Financial Overview

Table 200      Kaneka Eurogentec S.A.  Company Overview

Table 201      Kaneka Eurogentec S.A.  Financial Overview

Table 202      Integrated DNA Technologies, Inc.  Company Overview

Table 203      Integrated DNA Technologies, Inc.  Financial Overview

Table 204      LGC Biosearch Technologies Company Overview

Table 205      LGC Biosearch Technologies Financial Overview

Table 206      Eurofins Genomics Company Overview

Table 207      Eurofins Genomics Financial Overview

Table 208      General Electric   Company Overview

Table 209      General Electric   Financial Overview

Table 210      Genscript Company Overview

Table 211      Genscript Financial Overview

Table 212      Danaher Company Overview

Table 213      Danaher Financial Overview

Table 214      TriLink BioTechnologies Company Overview

Table 215      TriLink BioTechnologies Financial Overview

Table 216      Biolytic Lab Performance Inc.  Company Overview

Table 217      Biolytic Lab Performance Inc.  Financial Overview

Table 218      PolyGen GmbH Company Overview

Table 219      PolyGen GmbH Financial Overview

Table 220      Quintara Biosciences Company Overview

Table 221      Quintara Biosciences Financial Overview

Table 222      Twist Bioscience Company Overview

Table 223      Twist Bioscience Financial Overview

Table 224      GENERI BIOTECH Company Overview

Table 225      GENERI BIOTECH Financial Overview

Table 226      Ionis Pharmaceuticals Company Overview

Table 227      Ionis Pharmaceuticals Financial Overview

Table 228      Maravai LifeSciences Company Overview

Table 229      Maravai LifeSciences Financial Overview   

         

Market Segmentation

By Product & Services

  • Oligonucleotide Synthesis Products

  1. Oligonucleotide Synthesis Equipment (Synthesizers)

  2. Oligonucleotide Synthesis Reagents & Consumables

  • Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)

  1. Primers

  2. Probes

  3. Linkers & Adaptors

  • Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)

  1. Large-Scale Oligonucleotide Synthesis

  2. Intermediate-Scale Oligonucleotide Synthesis

  3. Small-Scale Oligonucleotide Synthesis

By Application

  • Research

  1. PCR

  2. qPCR/RTqPCR

  3. Sequencing

  4. Gene Synthesis

  5. Other Research Applications

  • Therapeutics

  1. RNAi Oligonucleotide-based Therapies

  2. DNA/Antisense oligonucleotide-based Therapies

  3. Immunotherapy (CpG Oligonucleotide-based Therapies)

  4. Nucleic Acid Aptamers

  • Diagnostics

By End User

  • Pharmaceutical and Biotechnology Companies

  • Academic & Research Institutes

  • Diagnostic Laboratories

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Major factors driving the growth of Global Oligonucleotide Synthesis Market include rising autoimmune disease prevalence, expanding use of oligonucleotide synthesis, rising biosimilars' cost-effectiveness, rising government investments in healthcare infrastructure, and rising research and development capabilities.
Ans: Global Oligonucleotide Synthesis Market size is estimated at 5.99 billion in 2022.
Ans: The pharmaceutical and biotechnology companies segment holds the highest market share in Global Oligonucleotide Synthesis Market.
Ans: The oligonucleotide synthesis segment accounted for the highest market share in Global Oligonucleotide Synthesis Market.
Ans: Key players in Global Oligonucleotide Synthesis Market include Thermo Fisher Scientific, Merck KgaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, and Maravai LifeSciences. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732216422)
}